Ligand Pharmaceuticals LGND Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's deferred taxes?
- Ligand Pharmaceuticals (LGND) reported deferred taxes of $13.53M in Q1 2026.
- How has Ligand Pharmaceuticals's deferred taxes changed year-over-year?
- Ligand Pharmaceuticals's deferred taxes increased by 53.0% year-over-year, from $8.84M to $13.53M.
- What is the long-term trend for Ligand Pharmaceuticals's deferred taxes?
- Over 3 years (2022 to 2025), Ligand Pharmaceuticals's deferred taxes has grown at a 3.1% compound annual growth rate (CAGR), from -$20.72M to -$22.68M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.